Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

PerkinElmer, Inc.. (11/30/15). "Press Release: PerkinElmer Launches Vectra 3 System for Quantitative Pathology Imaging Research". Waltham, MA.

Organisations Organisation PerkinElmer Inc. (NYSE: PKI)
  Group PerkinElmer (Group)
  Organisation 2 APCO Worldwide Inc.
Products Product Vectra® 3 pathology imaging system
  Product 2 inForm® Image Analysis Software
Persons Person Kim, Brian (PerkinElmer 201511 President Life Sciences + Technology)
  Person 2 Cizowski, Alison (APCO Worldwide 201511)
     


New Seven Color Multiplexing and Visualization Tools Help Accelerate Cancer Research


PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its Vectra® 3 automated, high-throughput quantitative pathology imaging system. This solution's new seven color multiplexing and visualization capabilities are designed to enable pathologists and oncologists conducting research to gain a deeper level of understanding of disease mechanisms related to new cancer immunotherapy approaches.

The Vectra 3 system visualizes, analyses, quantifies and phenotypes immune cells in situ in formalin-fixed paraffin-embedded (FFPE) tissue sections, a process that can help provide researchers critical insight into the role of immune cells within solid tumors and the tumor microenvironment. It incorporates 10x whole slide imaging and the Phenochart™ whole slide viewer, allowing researchers to annotate and navigate slides with interactive interfaces to better identify regions of interest for detailed multispectral acquisition.

Unlike alternative instrumentation, limited by the number of colors that can be imaged on one slide, the Vectra 3 system can separate up to seven colors. This multiplexing capability enables identification and quantification of multiple biomarkers and reveals spatial context within a digital workflow to assist researchers with better, faster decisions.

"With its ability to resolve multiple biomarkers in a single tissue section, this new system provides an innovative approach to help researchers more deeply analyze cancer mechanisms and potentially develop breakthrough immunotherapies for better health outcomes," said Brian Kim, President, Life Sciences & Technology, PerkinElmer. "The information may eventually allow for improved stratification of patients for clinical research, further unlocking the potential of precision medicine."

The Vectra 3 system is part of PerkinElmer's Phenoptics™ workflow solutions for quantitative pathology research applications. Phenoptics solutions help researchers fully characterize immune cells and tumor cells in situ within tissue, enabling visualization and analysis of complex cell interactions in ways that are difficult to achieve with other methods.

Combined with PerkinElmer's inForm® image analysis software, which automatically identifies and quantifies cell populations in tissue, the Vectra 3 system provides researchers the power of multiplexed biomarker imaging and quantitative analysis within a familiar digital workflow. PerkinElmer's Phenoptics portfolio also includes the Mantra™ quantitative pathology workstation, Opal® research kits, and inForm software.

For more information on PerkinElmer's Phenoptics solutions, please visit www.perkinelmer.com/cancer-immunology.


About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2014, has about 7,700 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Media Contact:
Alison Cizowski
+1 617-399-4914
perkinelmerlss@apcoworldwide.com

   
Record changed: 2016-01-27

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for PerkinElmer (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px